EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)

Phil A Hart, Dana K Andersen, Melena D Bellin, Yogish C Kudva, Frederico G S Toledo, Mark O Goodarzi, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)

Pancreatology · 2026-06 · 26 (4) · 581-586

DOI: 10.1016/j.pan.2026.04.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pancreatology, 2026-06. Verfasst von Phil A Hart und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Ele…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreatitis, Chronic, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Stanford University, Ohio State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes secondary to diseases of the exocrine pancreas, including chronic pancreatitis (CP) and pancreatic cancer (PDAC), is easily confused with type 2 diabetes (T2D). Misdiagnosis as T2D is common due to poor understanding of the underlying pathophysiology of these diabetes subtypes. In this review, we highlight contributions from our research group to further characterize the distinctions between CP-DM and PDAC-DM as it relates to postprandial response to pancreatic polypeptide (PP) and key metabolic alterations compared to T2D. In general, the PP response is blunted, and there is relatively lower insulin secretion, higher insulin sensitivity, and alpha cell dysregulation in CP-DM and PDAC when compared to T2D. Additionally, we provide updates regarding ongoing work to use clinical and genetic data to model the prediction of incident CP-DM. Lastly, we identify remaining knowledge gaps to further improve the diagnosis and treatment of type 3c diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPancreatitis, ChronicDiabetes MellitusHumansDiabetes Mellitus, Type 2Pancreatic PolypeptideInsulinAnimals

Substanzen

Pancreatic PolypeptideInsulin

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: Philip.hart@osumc.edu.
  • Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Departments of Pediatrics and Surgery, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Förderung

  • NIDDK NIH HHS
  • Stanford University
  • Ohio State University
  • University of Florida
  • University of Texas at Austin
  • Cedars-Sinai Medical Center
  • University of Pittsburgh
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Hart, P. A., Andersen, D. K., Bellin, M. D., Kudva, Y. C., Toledo, F. G. S., Goodarzi, M. O., & Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) (2026). Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Pancreatology, 26(4), 581-586. https://doi.org/10.1016/j.pan.2026.04.001

Vancouver

Hart PA, Andersen DK, Bellin MD, Kudva YC, Toledo FGS, Goodarzi MO, et al. Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Pancreatology. 2026;26(4):581-586. doi:10.1016/j.pan.2026.04.001

BibTeX
@article{Hart2026,
  author = {Hart, Phil A and Andersen, Dana K and Bellin, Melena D and Kudva, Yogish C and Toledo, Frederico G S and Goodarzi, Mark O and Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC), Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)},
  title = {Diabetes secondary to chronic pancreatitis and pancreatic cancer: Observations from the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)},
  journal = {Pancreatology},
  year = {2026},
  volume = {26},
  number = {4},
  pages = {581--586},
  doi = {10.1016/j.pan.2026.04.001}
}
Kostenlos starten →